Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 2
A Phase II, Nonrandomized, Single-Arm Study of Elranatamab Outpatient Administration in Patients With Relapsed/Refractory Multiple Myeloma (CORE-MM)
This is a Phase II, open-label, nonrandomized, single-arm study of elranatamab that will be administered in the outpatient setting in 2 sequential cohorts of p…
Multiple Myeloma (MM)Multiple Myeloma RefractoryMultiple Myeloma in Relapse+1 more
Estimated
~$10 – $8,750
SCRI Development Innovations, LLCNCT07637578
Phase 2
A Phase II, Open-Label, Multicenter Study of Inobrodib in Combination With Pomalidomide and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
The purpose of this study is to learn more about the anti-cancer activity of inobrodib, when given in combination with pomalidomide and dexamethasone, in patie…
Multiple Myeloma RefractoryMultiple Myeloma in Relapse
Estimated
~$10 – $8,750
CellCentric Ltd.NCT07096778